Follow-up in patients treated for head and neck cancer

被引：18

作者：

Kawecki A. ^{[1
]}

Krajewski R. ^{[1
]}

机构：

[1] Head and Neck Cancer Department, Cancer Center - M. Sklodowska-Curie Memorial Institute, 02-781 Warsaw

来源：

memo - Magazine of European Medical Oncology | 2014年 / 7卷 / 2期

关键词：

Head and neck cancer; Metastases; Oncological follow-up; Recurrence; Second primary tumor;

D O I：

10.1007/s12254-014-0143-y

中图分类号：

学科分类号：

摘要：

Principles of follow-up management in patients treated for head and neck tumors are not very strictly defined, and practice varies between countries, centers, and specialists. Details of follow-up procedures, including timing of outpatient visits and diagnostic imaging, are specific for tumor types and localizations but also depend on treatment modalities used, availability of diagnostic procedures, and socioeconomic factors. The authors describe general principles of follow-up in head and neck cancer patients. Clinical observation and laboratory and imaging studies in patients who had received radical treatment should focus on early identification of recurrent or second primary tumors to allow for a salvage radical therapy. In patients who initially had received a palliative care, the follow-up should focus on proper management of symptoms. © 2014 The Author(s).

引用

页码：87 / 91

页数：4

共 29 条

[1]

Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Et al., GLOBOCAN 2012 V1.0, (2013)

[2]

Vermorken J.B., Specenier P., Optimal treatment for recurrent/metastatic head and neck cancer, Ann Oncol, 21, SUPPL. 7, (2010)

[3]

Kearney P.L., Watkins J.M., Shirai K., Wahlquist A.E., Fortney J.A., Garrett-Mayer E., Et al., Salvage resection for isolated local and/or regional failure of head/neck cancer following definitive concurrent chemoradiotherapy case series and review of the literature, McGill J Med, 13, 2, (2011)

[4]

Lee D.H., Roh J.-L., Baek S., Jung J.H., Choi S.-H., Nam S.Y., Et al., Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma, Otolaryngol Head Neck Surg, 149, 4, pp. 579-586, (2013)

[5]

Goodwin Jr. W.J., Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means?, Laryngoscope, 110, 3 PART 2 SUPPL. 93, pp. 1-18, (2000)

[6]

De Visscher A.V.M., Manni J.J., Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: Does it make sense?, Archives of Otolaryngology - Head and Neck Surgery, 120, 9, pp. 934-939, (1994)

[7]

Machtay M., Moughan J., Trotti A., Garden A.S., Weber R.S., Cooper J.S., Et al., Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis, J Clin Oncol, 26, 21, pp. 3582-3589, (2008)

[8]

Maguire P.D., Meyerson M.B., Neal C.R., Hamann M.S., Bost A.L., Anagnost J.W., Ungaro P.C., Pollock H.D., McMurray J.E., Wilson E.P., Kotwall C.A., Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community, International Journal of Radiation Oncology Biology Physics, 58, 3, pp. 698-704, (2004)

[9]

Meyer F., Fortin A., Wang C.S., Liu G., Bairati I., Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy, Int J Radiat Oncol, 82, 4, pp. 1454-1462, (2012)

[10]

Evidence-based Management Strategies for Oral Complication from Cancer Treatment, (2011)

← 1 2 3 →